Description

Clabax OD (Clarithromycin) Tablets with Prolonged Release 500 mg. №5

Composition

Active ingredient: Clarithromycin 500 mg.

Other ingredients: Cellulose, hypromellose, lactose, magnesium stearate, povidone, talc, titanium dioxide, and more.

Mechanism of Action

Clarithromycin, a macrolide antibiotic, inhibits bacterial protein synthesis, thereby halting bacterial growth and spread in the body. This mechanism of action renders clarithromycin effective against a broad spectrum of Gram-positive and Gram-negative bacteria.

Pharmacological Properties

Clabax OD tablets contain clarithromycin, which exhibits bacteriostatic activity by interfering with bacterial protein synthesis. The prolonged-release formulation ensures sustained therapeutic levels of the drug, enhancing efficacy and patient compliance.

Indications for Use

Clabax OD tablets are indicated for the treatment of bacterial infections caused by susceptible microorganisms. Common indications include respiratory tract infections, skin and soft tissue infections, and more.

Contraindications

Do not use Clabax OD tablets if:

• You are allergic to clarithromycin or any other macrolide antibiotics.
• You are taking colchicine in patients with renal or hepatic impairment.
• You are using medications like ergotamine or dihydroergotamine.

Side Effects

Common side effects of Clabax OD tablets may include gastrointestinal disturbances, allergic reactions, and changes in taste perception. Contact your healthcare provider if you experience severe or persistent side effects.

Usage Instructions

Recommended dosage: One tablet once daily. Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.

Take Clabax OD tablets as prescribed by your healthcare provider. Follow all instructions on the prescription label to ensure optimal treatment outcomes.

Benefits Compared to Analogues

Clabax OD tablets offer the advantage of prolonged release, providing sustained drug levels for enhanced efficacy and convenience. This formulation may improve patient compliance and treatment outcomes compared to immediate-release counterparts.

Suitable Patient Groups

Clabax OD tablets are suitable for use in adults, including elderly patients, and adolescents. Dosage adjustments may be necessary in patients with renal or hepatic impairment. Consult a healthcare provider for personalized dosing recommendations.

Storage and Shelf Life

Store Clabax OD tablets in a cool, dry place away from direct sunlight. Follow the storage instructions provided on the packaging. Check the expiration date and do not use expired medication.

Packaging Description

Clabax OD tablets are packaged in blister packs to ensure individual tablet protection and ease of administration. Each pack contains 5 tablets of 500 mg strength.

Clinical Evidence and Proven Effectiveness

Clarithromycin, the active ingredient in Clabax OD tablets, has demonstrated efficacy in treating various bacterial infections. Studies published in reputable journals, such as the International Journal of Antimicrobial Agents, support the effectiveness of clarithromycin against a diverse range of pathogens.

Clinical studies have shown that prolonged-release formulations of clarithromycin, like Clabax OD tablets, provide sustained therapeutic drug levels, optimizing treatment outcomes and patient adherence. The controlled release profile ensures consistent drug concentrations, enhancing the drug’s efficacy in combating infections.